Neurotrope Issues Statement On Eli Lilly's Solanezumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to Neurotrope Issues Statement On Eli Lilly's Solanezumab
Neurotrope, Inc. Common (NASDAQ: NTRP) Delayed: 1.62 -0.01 (0.61%)
Previous Close $1.63    52 Week High $0.80 
Open $1.64    52 Week Low $0.20 
Day High $1.70    P/E N/A 
Day Low $1.62    EPS $0.00 
Volume 63,532